Bristol Myers Squibb (NYSE: BMY) has presented data that reinforces the benefits of its immuno-oncology blockbuster Opdivo (nivolumab) in the earlier stages of melanoma.
2022
New Zealand researchers use world-first technology to discover how melanin protects skin from UV radiation
A maze of mirrors and lenses lies inside Victoria University’s laser lab, and it’s unlocking the secrets of the skin.
Skin cancer awareness takes John Elliott on a journey of a lifetime with six camels and dog, ending in the Midwest
A Perth businessman who gave up city life for the beaten track has finished his marathon 12,000-kilometre trek across Australia with his six camels and dog, in the West Australian Midwest town of Geraldton
Cancer Vaccine May be Effective for Melanoma Patients
A researcher suggests that novel immune modulating cancer therapies like cancer vaccines can be more effective and safer alternative to previous cancer immunotherapies.